Skip to main content
Have a personal or library account? Click to login
The role of appetite-controlling hormones in the development of eating disorders in diabetic 2 patients Cover

The role of appetite-controlling hormones in the development of eating disorders in diabetic 2 patients

Open Access
|Sep 2022

Abstract

Binge eating disorder (BED) and night eating syndrome (NES) are common eating disorders (EDs) in individuals with diabetes type 2 (DT2). They worsen metabolic control, have a negative impact on physical and mental health and reduce quality of life. The roles of appetite-controlling hormones – leptin and ghrelin – is not clear enough in EDs and need to be investigated in order to establish new approaches and markers of EDs. Aim: To assess the difference in leptin and ghrelin levels in DT2 patients with and without EDs. 57 patients with DT2 were involved in the study. After physical examination and screening for EDs, blood samples for leptin and ghrelin measuring were obtained.

Results: 19 participants (33.3%) were screened positively for ED (BE or NES). Leptin levels were higher in participants with ED (p<0.05). Conversely, ghrelin levels were lower in those with BE or NES (p<0.05).

Leptin level is increased in DT2 individuals with BED and NES, whereas ghrelin is decreased. Leptin and ghrelin alterations maintain emotional eating, increase the frequency of binge and night eating episodes. In screening for EDs, assessing leptin and ghrelin levels will facilitate obesity reduction and improve metabolic control in diabetic patients.

DOI: https://doi.org/10.2478/cipms-2022-0016 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 86 - 88
Submitted on: Nov 8, 2021
Accepted on: May 20, 2022
Published online: Sep 2, 2022
Published in print: Aug 1, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services

© 2022 Alina Urbanovych, Fedir Laniush, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.